Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-059573
Filing Date
2013-11-19
Accepted
2013-11-19 10:12:52
Documents
1
Period of Report
2013-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd395704.html 4  
1 FORM 4 rrd395704.xml 4 2954
  Complete submission text file 0001181431-13-059573.txt   4491
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 801 CORPORATE CENTER DRIVE -SUITE 210 RALEIGH NC 27607
Business Address
Sirgo Mark A (Reporting) CIK: 0001301715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 131228832